Integrin alpha 3 (ITGA3) Human Gene Knockout Kit (CRISPR)
CAT#: KN217882BN
ITGA3 - human gene knockout kit via CRISPR, HDR mediated
HDR-mediated knockout kit validation
USD 1,290.00
4 Weeks*
Specifications
Product Data | |
Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
Donor DNA | mBFP-Neo |
Symbol | Integrin alpha 3 |
Locus ID | 3675 |
Disclaimer | The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process. |
Reference Data | |
RefSeq | NM_002204, NM_005501 |
Synonyms | CD49C; FRP-2; GAP-B3; GAPB3; ILNEB; MSK18; VCA-2; VL3A; VLA3a |
Summary | 'The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function as cell surface adhesion molecules. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 3 subunit. This subunit joins with a beta 1 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. Expression of this gene may be correlated with breast cancer metastasis. [provided by RefSeq, Oct 2015]' |
Documents
Product Manuals |
FAQs |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN217882 | ITGA3 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN217882LP | ITGA3 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN217882RB | ITGA3 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN417882 | ITGA3 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
USD 1,290.00 |
|
GA102466 | ITGA3 CRISPRa kit - CRISPR gene activation of human integrin subunit alpha 3 |
USD 1,290.00 |
{0} Product Review(s)
Be the first one to submit a review